Klein Hersh: Precision Executive Search
Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Whether you are a new company pursuing bold new science, a recently established biotech looking to achieve the next level, or a portfolio leader propelling breakthrough new drugs to patients who need them, Klein Hersh delivers the leaders that will make a difference in reaching your goals.
What Sets Us Apart
Key Stats
We know your industry because it’s our industry too. With an average tenure of 11 years, our team is deeply immersed in every facet of life sciences and healthcare. Always available and dedicated to your success, we move with precision and collaboration at every step.
The election of Joseph R. Biden Jr. to the Presidency promises significant change in Washington, D.C. for the next four years. Many questions remain about whether the incoming administration will be able to achieve its agenda, for better or worse, depending on one’s outlook – and the results of two Senate races still to be
New State Capital Partners, based in Larchmont, NY, has taken an equity investment stake in Horsham, PA-based Klein Hersh International, an executive search firm focused on the life sciences and healthcare industries. New State was advised on the transaction by Morgan Lewis (legal), Duff & Phelps (financial), L.E.K. Consulting (industry), and Citizens Bank (M&A advisory).
Executive recruitment firm Klein Hersh International has placed James Burns as the new chief executive officer for San Diego, CA-based Locana Inc., a leading RNA-targeting gene therapy company. Dr. Burns had been serving as CEO for biotechnology company Casebia Therapeutics, where he led the team in discovering and developing new CRISPR/Cas9-based breakthrough therapeutics to treat
The competitive landscape of the life sciences industry is transforming executive recruiting. “Growing pressure to rapidly advance scientific discovery and expand market share is making the competition to attract top talent as fierce as ever,” this according to a new report authored by Dan Strauss, client partner and head of the pharmacovigilance and risk management